Source link : https://newshealth.biz/health-news/mrd-assessment-may-refine-prognosis-after-car-t-for-follicular-lymphoma/
A study presented at the American Society of Clinical Oncology (ASCO) annual meeting suggested that circulating tumor (ct)DNA-based measurable residual disease (MRD) assessment may provide prognostic information for patients with relapsed or refractory follicular lymphoma treated with lisocabtagene maraleucel (liso-cel; Breyanzi). In this MedPage Today video, Yazeed Sawalha, MD, of the Ohio State University Wexner […]
The post MRD Assessment May Refine Prognosis After CAR-T for Follicular Lymphoma first appeared on News Health.
—-
Author : News Health
Publish date : 2026-07-16 18:16:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8